# Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

> **NCT01834742** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 161 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** NER1006
- **DRUG:** NER1006
- **DRUG:** NER1006
- **DRUG:** Moviprep
- **DRUG:** NER1006
- **DRUG:** NER1006
- **DRUG:** NER1006
- **DRUG:** NER1006

## Key facts

- **NCT ID:** NCT01834742
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834742, "Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01834742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*